Staphylococcal antigen composition comprising an isolated S. aureus type 5 antigen an isolated S. aureus type 8 antigen an isolated S. aureus 336 antigen an isolated S. aureus alpha-toxin antigen and an isolated Staphylococcal leukocidin antigen
Disclosed is a Staphylococcal antigen composition comprising (i) an isolated S. aureus Type 5 antigen, (ii) an isolated S. aureus Type 8 antigen, (iii) an isolated S. aureus 336 antigen, (iv) an isolated S. aureus alpha-toxin antigen and (v) an isolated Staphylococcal leukocidin antigen. The disclosed composition is used in the manufacture of a medicament for treating or preventing S. aureus infection.